The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study

Por van Hylckama Vlieg, A, Helmerhorst, F M, Vandenbroucke, J P, Doggen, C J M, Rosendaal, F R
Publicado em 2009

Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis

Por Stegeman, Bernardine H, de Bastos, Marcos, Rosendaal, Frits R, van Hylckama Vlieg, A, Helmerhorst, Frans M, Stijnen, Theo, Dekkers, Olaf M
Publicado em 2013

Differential associations of oral estradiol and conjugated equine estrogen with hemostatic biomarkers

Por Blondon, M., Van Hylckama Vlieg, A., Wiggins, K.L., Harrington, L.B., McKnight, B., Rice, K.M., Rosendaal, F.R., Heckbert, S.R., Psaty, B.M., Smith, N.L.
Publicado no J Thromb Haemost (2014)

Is there still room for additional common susceptibility alleles for venous thromboembolism?

Por Trégouët, D-A, Delluc, A., Roche, A., Derbois, C., Olaso, R., Germain, M., de Andrade, M., Tang, W., Chasman, D. I., van Hylckama Vlieg, A., Reitsma, P., Kabrhel, C., Smith, N., Morange, P-E.
Publicado no J Thromb Haemost (2016)